See Also:
The Beamline Bulletin
Submissions from 2025
Benchmarking the efficacy of salvage systemic therapies for recurrent meningioma: A RANO group systematic review and meta-analysis to guide clinical trial design, Rupesh Kotecha, Eyub Akdemir, Tugce Kutuk, Manmeet Ahluwalia, Michael McDermott, Yazmin Odia, and Minesh Mehta
Integrating a novel tablet-based digital neurocognitive assessment tool in brain metastases patients, Eyub Akdemir, Selin Gurdikyan, Yazmin Odia, Thailin Reyes, Miguel Ramirez Menendez, Sreenija Yarlagadda, Matthew Hall, Omer Gal, Robert Press, D Jay Wieczorek, Cecilia Lee, Ranjini Tolakanahalli, Alonso Gutierrez, Michael McDermott, Manmeet Ahluwalia, Minesh Mehta, and Rupesh Kotecha
Comparing Survival Outcomes of Whole Pelvic vs. Bladder-Only Radiation in Muscle-Invasive Bladder Cancer, Mohammad Ganiyani, Atulya Khosla, Adeel Kaiser, Marcio Fagundes, and Rohan Garje
MR-Guided Single-Fraction Stereotactic Ablative Body Radiation Therapy for Extracranial Metastases: The Miami Cancer Institute Experience, Michael Chuong, Robert Herrera, Kathryn Mittauer, Carolina Rojas, Muni Rubens, Adeel Kaiser, Noah Kalman, Nema Bassiri, Antonio Ucar, Federico Albrecht, Fernando deZarraga Jr, Paul Kaywin, Santiago Aparo, Sarah Joseph, Alonso Gutierrez, and Rupesh Kotecha
Routine machine quality assurance tests for a self-shielded gyroscopic radiosurgery system, Cecilia Lee, Ranjini Tolakanahalli, D Jay Wieczorek, Minesh Mehta, Michael McDermott, Rupesh Kotecha, and Alonso Gutierrez
Multidisciplinary management strategies for recurrent brain metastasis after prior radiotherapy: An overview, Rupesh Kotecha and Alonso La Rosa
Clinical and Genetic Markers of Vascular Toxicity in Glioblastoma Patients: Insights from NRG Oncology RTOG-0825, Minesh Mehta
Recent advances in Tumor Treating Fields (TTFields) therapy for glioblastoma, Rupesh Kotecha
Ablative Five-Fraction CT Versus MR-Guided Stereotactic Body Radiation Therapy for Pancreatic Cancer: In Silico Evaluation of Interfraction Anatomic Changes as a Rationale for Online Adaptive Replanning, Adeel Kaiser, Nicole Luther, Kathryn Mittauer, Amna Gul, Robert Herrera, Mukesh Roy, Ashley Fellows, Amy Rzepczynski, Will Deere, Matthew Hall, Rupesh Kotecha, Nema Bassiri Gharb, Alonso Gutierrez, and Michael Chuong
Analysis of Medicare Reimbursement Trends in Medical and Radiation Oncology, Minesh Mehta
Assessment of outcomes and machine Learning-based models to predict local failure risk following stereotactic radiosurgery for small brain metastases, Sreenija Yarlagadda, Yanjia Zhang, Anshul Saxena, Tugce Kutuk, Ranjini Tolakanahalli, Haley Appel, Roberto Herrera, Matthew Hall, Robert Press, D Jay Wieczorek, Cecilia Lee, Tatiana Bejarano, Michael McDermott, Alonso Gutierrez, Minesh Mehta, and Rupesh Kotecha
Back in the RACE: (Re) Defining the Role of Radiation Therapy in Liver and Gallbladder Cancers, Michael Chuong
Beyond Randomized Controlled Trials: Embracing Pragmatism for Evidence-Based Online Adaptive Radiation Therapy, Michael Chuong
Clinical Outcomes After Proton Therapy Reirradiation for Recurrent Malignant Glioma: Analysis From the Prospective Proton Collaborative Group Registry, Omer Gal, Rupesh Kotecha, and Robert Press
Contrast-enhancing Lesions Induced by Central Nervous System-directed Intensity Modulated Proton Therapy: Distribution Patterns, Kinetics, Risk Factors, and Outcomes, Omer Gal, Jen Yu, Minesh Mehta, Matthew Hall, Robert Press, Yazmin Odia, Michael McDermott, Zachary Fellows, Andrew Wroe, Alonso Gutierrez, and Rupesh Kotecha
Correlation Between Neurocognitive Outcomes and Neuroaxonal Connectome Alterations After Whole Brain Radiotherapy: A Proof-of-Concept Study, Sreenija Yarlagadda, Star Belnap, John Candela, Tugce Kutuk, Thailin Companioni Reyes, Miguel Ramirez Menendez, Matthew Hall, Robert Press, Yazmin Odia, Minesh Mehta, Michael McDermott, and Rupesh Kotecha
Current Status of Proton Craniospinal Irradiation for Solid Tumor Leptomeningeal Disease, Omer Gal and Rupesh Kotecha
Dual Immune Check Point Blockade in MGMT-Unmethylated Newly Diagnosed Glioblastoma: NRG Oncology BN007, a Randomized Phase II/III Clinical Trial, Alonso Gutierrez and Minesh Mehta
Evolving Trends and Patterns of Utilization of Magnetic Resonance-Guided Radiotherapy at a Single Institution, 2018-2024, Robert Herrera, Eyub Akdemir, Rupesh Kotecha, Kathryn Mittauer, Matthew Hall, Adeel Kaiser, Nema Bassiri Gharb, Noah Kalman, Yonatan Weiss, Tino Romaguera, Diane Alvarez, Sreenija Yarlagadda, Ranjini Tolakanahalli, Alonso Gutierrez, Minesh Mehta, and Michael Chuong
Initial three- and half-year machine performance assessment of a superficial radiation therapy unit, Cecilia Lee, William Romaguera, Stephan Davis, D Jay Wieczorek, Vibha Chaswal, Ranjini Tolakanahalli, Minesh Mehta, Noah Kalman, and Alonso Gutierrez
Interventional stereotactic radiotherapy (brachytherapy) for unresected brain metastases: Systematic review of outcome and toxicity, Ranjini Tolakanahalli and Rupesh Kotecha
Leptomeningeal Metastasis, an Evolving Frontier for Radiation Oncology, Rupesh Kotecha
Leptomeningeal Spread in EGFR Mutation Non-Small Cell Lung Cancer: No More One Size Fits All, Omer Gal and Rupesh Kotecha
Multi-Institutional Comparison of Ablative 5-Fraction Magnetic Resonance-Guided Online Adaptive Versus 15/25-Fraction Computed Tomography-Guided Moderately Hypofractionated Offline Adapted Radiation Therapy for Locally Advanced Pancreatic Cancer, Michael Chuong, Robert Herrera, Kathryn Mittauer, Muni Rubens, Adeel Kaiser, Nema Bassiri Gharb, Alonso Gutierrez, Antonio Ucar, Fernando De Zarraga, and Santiago Aparo
Phase I Dose Escalation Trial Combining Olaparib and Thoracic Radiation Therapy in Extensive-Stage Small Cell Lung Cancer, Rupesh Kotecha
Practice Patterns in Management of Low- to Intermediate-Grade Salivary Gland Carcinoma: A Multi-Institutional Study, Noah Kalman and Geoffrey Young
Proton Beam Therapy for Pancreatic Tumors: A Consensus Statement from the Particle Therapy Cooperative Group Gastrointestinal Subcommittee, Adeel Kaiser, Andrew Wroe, and Michael Chuong
Proton Craniospinal Irradiation for Patients with Solid Tumor Leptomeningeal Disease: Real-World Feasibility, Toxicity, and Outcome Analysis, Omer Gal, Alonso La Rosa de los Rios, Matthew Hall, Andrew Wroe, Alonso Gutierrez, Yazmin Odia, Minesh Mehta, Rupesh Kotecha, Robert Press, and Zachary Fellows
Pulsed reduced dose rate radiotherapy: a narrative review, Alonso La Rosa de los Rios, Minesh Mehta, Alonso Gutierrez, and Rupesh Kotecha
Quantifying and addressing self-defined needs in cancer patients, Minesh Mehta and Matthew Hall
Radiosurgical Management of Cavernous Sinus Hemangioma: Systematic Review, Meta-analysis, and International Stereotactic Radiosurgery Society Practice Guideline, Eyub Akdemir and Rupesh Kotecha
Range-compensated pencil beam scanning proton Arc therapy: a feasibility study, Alonso Gutierrez
Reirradiation in the Management of Locally Recurrent Rectal Adenocarcinoma, Michael Chuong
SAVI catheter digitization impact: A single institution multiuser uncertainty study, Vibha Chaswal, Juan Ramirez, Marc Morcos, Tino Romaguera, Usha Abraham, Siju George, James McCulloch, Maria-Amelia Rodrigues, Alonso Gutierrez, and Ranjini Tolakanahalli
Stereotactic Body Radiation Therapy for the Treatment of Adrenal Metastases - A Case-Based Radiosurgery Society Practice Guide and Review, Rupesh Kotecha
Stereotactic Magnetic Resonance Guided Adaptive Radiation Therapy for Infradiaphragmatic Oligometastatic Disease: Disrupting the One-Size-Fits-All Paradigm, Eyub Akdemir, Robert Herrera, Selin Gurdikyan, Lydia Hodgson, Sreenija Yarlagadda, Adeel Kaiser, Robert Press, Kathryn Mittauer, Nema Bassiri Gharb, Ranjini Tolakanahalli, Alonso Gutierrez, Minesh Mehta, Michael Chuong, and Rupesh Kotecha
Stereotactic Magnetic Resonance Guided Adaptive Radiation Therapy in One Fraction (SMART ONE): A Multicenter, Single-Arm, Phase 2 Trial, Michael Chuong, Kathryn Mittauer, Carolina Rojas, Noah Kalman, Muni Rubens, Ranjini Tolakanahalli, Alonso Gutierrez, Nema Bassiri Gharb, Minesh Mehta, and Rupesh Kotecha
Temporospatial tumor dynamic changes in glioblastoma during radiotherapy, Alonso La Rosa de los Rios, Kathryn Mittauer, Amy Rzepczynski, Michael Chuong, Nema Bassiri Gharb, Nicole McAllister, Matthew Hall, Robert Press, Alonso Gutierrez, Ranjini Tolakanahalli, Minesh Mehta, and Rupesh Kotecha
The Role of MR Guided Radiation Therapy in Pancreatic Cancer Treatment, Michael Chuong
Tip of the Iceberg or the Whole Titanic: Discrepant Representation of Glioblastoma on Different Imaging Modalities, Omer Gal and Rupesh Kotecha
Unraveling the Effects of Radiotherapy on the Blood Brain Barrier: Fact or Fiction?, Rupesh Kotecha and Minesh Mehta
Update to the RANO working group and EANO recommendations for the clinical use of PET imaging in gliomas, Minesh Mehta
Submissions from 2024
Evaluation of a non-metallic dual-port expander for intensity modulated proton therapy, Kristen McConnell, Zachary Fellows, James Kraus, Mauricio Acosta, Joseph Panoff, Eduardo Pons, Alonso Gutierrez, and Andrew Wroe
In Regard to Youssef et al, Noah Kalman and Sreenija Yarlagadda
Dosimetric comparison of magnetic resonance-guided radiation therapy, intensity-modulated proton therapy and volumetric-modulated arc therapy for distal esophageal cancer, Andrew Barsky, Andrew Wroe, Kathryn Mittauer, Adeel Kaiser, Roberto Herrera, Jen Yu, Alonso Gutierrez, Diane Alvarez, James McCulloch, Michael Kasper, Minesh Mehta, and Michael Chuong
Multi-institutional report of trastuzumab deruxtecan and stereotactic radiosurgery for HER2 positive and HER2-low breast cancer brain metastases, Sreenija Yarlagadda, Reshma Mahtani, Manmeet Ahluwalia, and Rupesh Kotecha
The Dust Has Finally Settled, but Is the View Any Clearer?, Michael Chuong
Initial feasibility cohort of temporally modulated pulsed proton re-irradiation (TMPPR) for recurrent high-grade intracranial malignancies, Alonso LaRosa, Zachary Fellows, Andrew Wroe, Len Coutinho, Eduardo Pons, Nicole McAllister, Ranjini Tolakanahalli, Tugce Kutuk, Matthew Hall, Robert Press, Michael McDermott, Yazmin Odia, Manmeet Ahluwalia, Minesh Mehta, Alonso Gutierrez, and Rupesh Kotecha
Low contralateral failure rate with unilateral proton beam radiotherapy for oropharyngeal squamous cell carcinoma: A multi-institutional prospective study from the proton collaborative group, Noah Kalman and Robert Press
SBRT vs. Conventional Radiotherapy for Painful Spinal Metastases: A Comparative Analysis of Randomized Trials and Practical Considerations, Omer Gal, Robert Rothrock, Alonso Gutierrez, Minesh Mehta, and Rupesh Kotecha
Surgically targeted radiation therapy versus stereotactic radiation therapy: A dosimetric comparison for brain metastasis resection cavities, Tugce Kutuk, Rupesh Kotecha, Raul Herrera, D Jay Wieczorek, Zachary Fellows, Vibha Chaswal, Alonso La Rosa De Los Rios, Vivek Mishra, Michael McDermott, Vitaly Siomin, Minesh Mehta, Alonso Gutierrez, and Ranjini Tolakanahalli
Surgically targeted radiation therapy versus stereotactic radiation therapy: A dosimetric comparison for brain metastasis resection cavities, Tugce Kutuk, Rupesh Kotecha, Raul Herrera, D Jay Wieczorek, Zachary Fellows, Vibha Chaswal, Alonso La Rosa De Los Rios, Vivek Mishra, Michael McDermott, Vitaly Siomin, Minesh Mehta, Alonso Gutierrez, and Ranjini Tolakanahalli
Hypofractionated versus standard fractionation radiotherapy for merkel cell carcinoma, Lauren Gonzalez, Muni Rubens, Sreenija Yarlagadda, Guilherme Rabinowits, and Noah Kalman
Pediatric Cranial Stereotactic Radiosurgery: Meta-Analysis and International Stereotactic Radiosurgery Society Practice Guidelines, Anshul Saxena, Md Ashfaq Ahmed, and Rupesh Kotecha
The IDH paradox: Meta-analysis of alkylating chemotherapy in IDH-wildtype and -mutant lower grade gliomas, Minesh Mehta
The IDH paradox: Meta-analysis of alkylating chemotherapy in IDH-wildtype and -mutant lower grade gliomas, Minesh Mehta
Upping the Ante in the Treatment of Gastrointestinal Cancer, Michael Chuong
TCF4 as a potential prognostic biomarker and an anticancer target in gastric cancer, Michael Chuong
Early experience and perioperative risk of GammaTile for upfront brain metastases: Report from a prospective multicenter study, Rupesh Kotecha and Manmeet Ahluwalia
NRG-BN002: Phase I study of ipilimumab, nivolumab, and the combination in patients with newly diagnosed glioblastoma, Minesh Mehta
An Update on H3K27M-altered Diffuse Midline Glioma: Diagnostic and Therapeutic Challenges in Clinical Practice, Eyub Akdemir, Yazmin Odia, Matthew Hall, Minesh Mehta, and Rupesh Kotecha
Clinical application of an institutional fractionated stereotactic radiosurgery (FSRS) program for brain metastases delivered with MRIdian(Ⓡ) BrainTx™, Alonso La Rosa De Los Rios, Kathryn Mittauer, D Jay Wieczorek, Cecilia Lee, Amy Rzepczynski, Michael Chuong, Tugce Kutuk, Nicole McAllister, Matthew Hall, Alonso Gutierrez, Ranjini Tolakanahalli, Minesh Mehta, and Rupesh Kotecha
Patient-specific quality assurance of dynamically-collimated proton therapy treatment plans, Alonso Gutierrez, Eduardo Pons, and Andrew Wroe
Utility of TTMV-HPV DNA in resolving indeterminate findings during oropharyngeal cancer surveillance, Noah Kalman and Sreenija Yarlagadda
Multidisciplinary Management of Isocitrate Dehydrogenase-Mutated Gliomas in a Contemporary Molecularly Defined Era, Rupesh Kotecha and Minesh Mehta
Establishing Updated Safety Standards for Independent (99)(m)Tc-MAA SPECT/CT Treatment Planning in Radioembolization, Taehyung Kim, Ripal Gandhi, Ranjini Tolakanahalli, Raul Herrera, Michael Chuong, Alonso Gutierrez, and Diane Alvarez
Case report: Intrafraction dose-guided tracking for gastrointestinal organ-at-risk isotoxicity delivery on an MR-guided radiotherapy system, Sreenija Yarlagadda, Yonatan Weiss, Michael Chuong, Nema Bassiri Gharb, Alonso Gutierrez, Rupesh Kotecha, Minesh Mehta, and Kathryn Mittauer
Stereotactic Body Radiation Therapy Versus Conventional Radiation Therapy for Painful Spinal Metastases: A Comparative Analysis of Randomized Trials and Practical Considerations, Omer Gal, Robert Rothrock, Alonso Gutierrez, Minesh Mehta, and Rupesh Kotecha
Tubarial gland sparing with intensity modulated radiation therapy for oropharyngeal cancers: A pilot study of dosimetric feasibility, Sreenija Yarlagadda, Nicole McAllister, Amy Rzepczynski, Tugce Kutuk, and Noah Kalman
Emerging potential of tumor treating fields as a treatment modality for pancreatic cancer: a narrative review of therapeutic evolution, Tugce Kutuk, Adeel Kaiser, and Michael Chuong
Quantifying the Dosimetric Impact of Proton Range Uncertainties on RBE-Weighted Dose Distributions in Intensity-Modulated Proton Therapy for Bilateral Head and Neck Cancer, Suresh Rana, Noufal Manthala Padannayil, Hina Saeed, and Michael Kasper
Evaluating the sensitivity of EQ-5D-5L in patients with brain metastases: a secondary analysis of NRG CC001, Minesh Mehta
Comparative evaluation of outcomes amongst different radiosurgery management paradigms for patients with large brain metastasis, Tugce Kutuk, Yanjia Zhang, Eyub Akdemir, Sreenija Yarlagadda, Ranjini Tolakanahalli, Matthew Hall, Alonso La Rosa De Los Rios, D Jay Wieczorek, Cecilia Lee, Haley Appel, Michael McDermott, Yazmin Odia, Manmeet Ahluwalia, Alonso Gutierrez, Minesh Mehta, Rupesh Kotecha, and Robert Press
Dosimetric comparison of magnetic resonance-guided radiation therapy, intensity-modulated proton therapy and volumetric-modulated arc therapy for distal esophageal cancer, Andrew Barsky, Jerry George, Andrew Wroe, Kathryn Mittauer, Adeel Kaiser, Roberto Herrera, Jen Yu, Alonso Gutierrez, Diane Alvarez, James McCulloch, Michael Kasper, Minesh Mehta, and Michael Chuong
Quality assurance of an established online adaptive radiotherapy program: patch and software upgrade, Michael Chuong, Rupesh Kotecha, Yonatan Weiss, Minesh Mehta, Alonso Gutierrez, and Kathryn Mittauer
Implications and interchangeability of meningioma biomarkers for clinical trials and clinical practice, Minesh Mehta
Comparative evaluation of the diagnostic and prognostic performance of CNSide™ versus standard cytology for leptomeningeal disease, Haley Appel, Muni Rubens, Mukesh Roy, Rupesh Kotecha, Matthew Hall, Minesh Mehta, Zhijian Chen, Manmeet Ahluwalia, and Yazmin Odia
Safety and pharmacokinetics of ONC201 (dordaviprone) administered two consecutive days per week in pediatric patients with H3 K27M-mutant glioma, Yazmin Odia, Doured Daghistani, and Matthew Hall
Selective DRD2 antagonist and ClpP agonist ONC201 in a recurrent non-midline H3 K27M-mutant glioma cohort, Yazmin Odia and Matthew Hall
In Reply to Cellini and Fiore, Michael Chuong
ONC201 (Dordaviprone) in Recurrent H3 K27M-Mutant Diffuse Midline Glioma, Yazmin Odia and Minesh Mehta
ONC201 (Dordaviprone) in Recurrent H3 K27M-Mutant Diffuse Midline Glioma, Yazmin Odia and Minesh Mehta